<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JBA</journal-id>
<journal-id journal-id-type="hwp">spjba</journal-id>
<journal-id journal-id-type="nlm-ta">J Biomater Appl</journal-id>
<journal-title>Journal of Biomaterials Applications</journal-title>
<issn pub-type="ppub">0885-3282</issn>
<issn pub-type="epub">1530-8022</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0885328211429193</article-id>
<article-id pub-id-type="publisher-id">10.1177_0885328211429193</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Optimization of composition, structure and mechanical strength of bioactive 3-D glass-ceramic scaffolds for bone substitution</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Baino</surname><given-names>Francesco</given-names></name>
<xref ref-type="aff" rid="aff1-0885328211429193">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ferraris</surname><given-names>Monica</given-names></name>
<xref ref-type="aff" rid="aff1-0885328211429193">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bretcanu</surname><given-names>Oana</given-names></name>
<xref ref-type="aff" rid="aff1-0885328211429193">1</xref>
<xref ref-type="aff" rid="aff2-0885328211429193">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Verné</surname><given-names>Enrica</given-names></name>
<xref ref-type="aff" rid="aff1-0885328211429193">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Vitale-Brovarone</surname><given-names>Chiara</given-names></name>
<xref ref-type="aff" rid="aff1-0885328211429193">1</xref>
<xref ref-type="corresp" rid="corresp1-0885328211429193"/>
</contrib>
</contrib-group>
<aff id="aff1-0885328211429193"><label>1</label>Materials Science and Chemical Engineering Department, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy</aff>
<aff id="aff2-0885328211429193"><label>2</label>School of Mechanical and Systems Engineering, Newcastle University, NE1 7RU, UK</aff>
<author-notes>
<corresp id="corresp1-0885328211429193">Chiara Vitale-Brovarone, Materials Science and Chemical Engineering Department, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy. Email: <email>chiara.vitale@polito.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>7</issue>
<fpage>872</fpage>
<lpage>890</lpage>
<permissions>
<copyright-statement>© The Author(s) 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Fabrication of 3-D highly porous, bioactive, and mechanically competent scaffolds represents a significant challenge of bone tissue engineering. In this work, Bioglass®-derived glass-ceramic scaffolds actually fulfilling this complex set of requirements were successfully produced through the sponge replication method. Scaffold processing parameters and sintering treatment were carefully designed in order to obtain final porous bodies with pore content (porosity above 70 %vol), trabecular architecture and mechanical properties (compressive strength up to 3 MPa) analogous to those of the cancellous bone. Influence of the Bioglass® particles size on the structural and mechanical features of the sintered scaffolds was considered and discussed. Relationship between porosity and mechanical strength was investigated and modeled. Three-dimensional architecture, porosity, mechanical strength and <italic>in vitro</italic> bioactivity of the optimized Bioglass®-derived scaffolds were also compared to those of CEL2-based glass-ceramic scaffolds (CEL2 is an experimental bioactive glass originally developed by the authors at Politecnico di Torino) fabricated by the same processing technique, in an attempt at understanding the role of different bioactive glass composition on the major features of scaffolds prepared by the same method.</p>
</abstract>
<kwd-group>
<kwd>Bioactivity</kwd>
<kwd>bone tissue engineering</kwd>
<kwd>glass</kwd>
<kwd>sponge replication</kwd>
<kwd>mechanical strength</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0885328211429193" sec-type="intro"><title>Introduction</title>
<p>Over the last 40 years, bioceramics have attracted increasing interest as implantable materials in the field of orthopaedic surgery and bone reconstruction.<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref>–<xref ref-type="bibr" rid="bibr4-0885328211429193">4</xref></sup> In the mid-1980s, the osteoconductive properties of calcium phosphates (CaPs), including primarily hydroxyapatite (HA), and β-tricalcium phosphate (β-TCP), led to their use as a promising alternative to autograft and allograft for bone tissue repair.<sup><xref ref-type="bibr" rid="bibr5-0885328211429193">5</xref></sup> Most of synthetic bone substitutes in current use are porous blocks of biphasic HA/β-TCP composites.<sup><xref ref-type="bibr" rid="bibr6-0885328211429193">6</xref></sup> The overall degradation rate of the material can be controlled by acting on the amount of β-TCP, which has a fast <italic>in vivo</italic> resorption rate as compared to HA, thereby leading to custom-made implant (slower resorption for patients with slower bone regeneration). However, the commercially available CaP implants are generally characterized by high brittleness associated to low crack resistance,<sup><xref ref-type="bibr" rid="bibr7-0885328211429193">7</xref></sup> which often makes them difficult to handle during surgery and therefore restricts their use to nonload bearing applications; furthermore, CaPs, although being similar to bone mineral from chemical and crystallographic viewpoints, are not properly bioactive and do not stimulate bone cells toward osteogenesis.<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref>,<xref ref-type="bibr" rid="bibr4-0885328211429193">4</xref></sup></p>
<p>As extensively emphasized by several authors, bioactive glasses have a great potential for overcoming the limitations of CaPs as they exhibit higher mechanical properties and are able to bond to bone creating a stable interface.<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref>–<xref ref-type="bibr" rid="bibr4-0885328211429193">4</xref>,<xref ref-type="bibr" rid="bibr8-0885328211429193">8</xref>–<xref ref-type="bibr" rid="bibr10-0885328211429193">10</xref></sup> Their bioactivity is due to the formation of a HA or apatite-like layer on their surface after contact with body fluids.<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref></sup> The first bioactive glass, called Bioglass®, was synthesized and investigated by Hench and co-workers in the early 1970s;<sup><xref ref-type="bibr" rid="bibr11-0885328211429193">11</xref></sup> since then, several glasses and glass-ceramics of various compositions have been proposed as bone graft biomaterials.<sup><xref ref-type="bibr" rid="bibr12-0885328211429193">12</xref></sup></p>
<p>Bioglass® has been marketed worldwide since 1985 as a fine particulate for dental application (Perioglas, NovaBone, USA) and since the mid 1990s in form of dense blocks and granulates of various size for bone defect filling in orthopaedics and dentistry. It has been also demonstrated that Bioglass® promotes stem cells differentiation into osteoblasts and that its ionic dissolution products have a direct effect in stimulating bone cells genes toward a path of regeneration and self-repair.<sup><xref ref-type="bibr" rid="bibr13-0885328211429193">13</xref>–<xref ref-type="bibr" rid="bibr15-0885328211429193">15</xref></sup></p>
<p>To the best of the authors’ knowledge, however, the use of porous Bioglass® in the surgical practice has not yet been introduced. In fact, the development of 3-D Bioglass® scaffolds for clinical use is currently in progress: although Bioglass® was demonstrated to be an excellent bioactive material for promoting bone tissue regeneration, all porous bodies produced from it exhibited relevant brittleness and poor mechanical strength. In 2006, Chen et al.<sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref></sup> pioneered the fabrication of glass-ceramic (GC) Bioglass®-derived scaffolds by the sponge replication technique: the scaffolds had porous content (&gt;85 %vol.) and 3-D architecture that closely mimicked those of cancellous bone, but their mechanical strength (0.3–0.4 MPa) was almost one order of magnitude lower than that of spongy bone (2–12 MPa<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref></sup>). One year later, Bretcanu et al.<sup><xref ref-type="bibr" rid="bibr17-0885328211429193">17</xref></sup> fabricated porous composites by coating foam-like GC-Bioglass® scaffolds with poly(3-hydroxybutyrate): the polymer strengthened the inorganic porous matrix acting as a glue and holding the glass-ceramic particles together when the scaffold struts begun to fail. The compressive strength of these porous composites (up to 1.5 MPa) was twice that of bare GC-Bioglass® scaffolds (0.3–0.4 MPa<sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref></sup>), but these results are still unsatisfactory for clinical use. In 2009, Wu et al.<sup><xref ref-type="bibr" rid="bibr18-0885328211429193">18</xref></sup> manufactured GC-Bioglass® scaffolds by using rice husk as a volatile pore former: the mechanical strength of these scaffolds ranged within 5.4–7.2 MPa and, therefore, was comparable to that of spongy bone, but their porosity content (∼45 %vol.) was below the lower threshold required for porous bone grafts (50–70 %vol.<sup><xref ref-type="bibr" rid="bibr19-0885328211429193">19</xref></sup>). Furthermore, these scaffolds exhibited a 3-D porous architecture far from that of spongy bone, with poorly interconnected elongated pores resembling the shape and size of the sacrificial rice husks.</p>
<p>Very recently, Bellucci et al.<sup><xref ref-type="bibr" rid="bibr20-0885328211429193">20</xref></sup> produced GC-Bioglass® scaffolds by combining sponge replication with polyethylene burning-out method, but no data about their mechanical properties have been reported yet.</p>
<p>It is evident that the achievement of a satisfactory compromise between pores content and adequate mechanical strength is a crucial issue in scaffolds manufacturing. Recently, Vitale-Brovarone et al.<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup> proposed an effective processing schedule to fabricate bioactive glass-ceramic scaffolds with promising properties (porosity &gt; 50 %vol., compressive strength &gt; 5 MPa) using CEL2 glass powder (a glass composition developed at Politecnico di Torino).<sup><xref ref-type="bibr" rid="bibr22-0885328211429193">22</xref></sup> This method for scaffolding was adopted in this work to fabricate Bioglass®-derived scaffolds able to be highly porous, mechanically competent, and bioactive at the same time. Furthermore, a comparison between architectural/mechanical features and bioactive behavior of the so-obtained Bioglass®- and CEL2-derived scaffolds is presented and discussed, in the attempt at understanding the role of different bioactive glass composition on the major features of scaffolds prepared by the same method.</p>
</sec>
<sec id="sec2-0885328211429193" sec-type="materials|methods"><title>Materials and methods</title>
<sec id="sec3-0885328211429193"><title>Starting glasses synthesis</title>
<p>Two silicate glasses, Bioglass® and CEL2, were used as starting materials for scaffolds fabrication; their molar compositions are listed in <xref ref-type="table" rid="table1-0885328211429193">Table 1</xref>. Bioglass® is a biomaterial well known for many years in the biomedical field<sup><xref ref-type="bibr" rid="bibr8-0885328211429193">8</xref></sup>; CEL2 is a silicate glass that has been originally developed and studied by Vitale-Brovarone and co-workers at Politecnico di Torino since the mid-2000s.<sup><xref ref-type="bibr" rid="bibr22-0885328211429193">22</xref>,<xref ref-type="bibr" rid="bibr23-0885328211429193">23</xref></sup> Both glasses were synthesized by melting high-purity raw products (Sigma-Aldrich) in a platinum crucible in air (<xref ref-type="table" rid="table2-0885328211429193">Table 2</xref>); the melt was then quenched into cold water to obtain a ‘frit’ that was ground by zirconia ball milling. Glass powders were eventually sieved to obtain particles with grain size below 32 µm to be used for fabricating the scaffolds.
<table-wrap id="table1-0885328211429193" position="float"><label>Table 1.</label><caption><p>Composition of starting glasses.</p></caption>
<graphic alternate-form-of="table1-0885328211429193" xlink:href="10.1177_0885328211429193-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Glass</th>
<th colspan="6">Composition (%mol.)<hr/></th>
</tr>
<tr><th>SiO<sub>2</sub></th>
<th>P<sub>2</sub>O<sub>5</sub></th>
<th>CaO</th>
<th>Na<sub>2</sub>O</th>
<th>MgO</th>
<th>K<sub>2</sub>O</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Bioglass®</td>
<td>46.1</td>
<td>2.6</td>
<td>26.9</td>
<td>24.4</td>
<td>–</td>
<td>–</td>
</tr>
<tr>
<td>CEL2</td>
<td>45.0</td>
<td>3.0</td>
<td>26.0</td>
<td>15.0</td>
<td>7.0</td>
<td>4.0</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table2-0885328211429193" position="float"><label>Table 2.</label><caption><p>Preparation of starting glasses.</p></caption>
<graphic alternate-form-of="table2-0885328211429193" xlink:href="10.1177_0885328211429193-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Glass</th>
<th>Raw products</th>
<th>Melting conditions</th>
</tr></thead>
<tbody align="left">
<tr>
<td rowspan="2">Bioglass®</td>
<td rowspan="2">SiO<sub>2</sub>, Ca<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>, CaCO<sub>3</sub>, Na<sub>2</sub>CO<sub>3</sub></td>
<td>1500°C for 1 h</td>
</tr>
<tr>
<td>(heating rate: 10°C·min<sup>−1</sup>)</td>
</tr>
<tr>
<td rowspan="2">CEL2</td>
<td rowspan="2">SiO<sub>2</sub>, Ca<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>, CaCO<sub>3</sub>, Na<sub>2</sub>CO<sub>3</sub>, (MgCO<sub>3</sub>)<sub>4</sub>ċ Mg(OH)<sub>2</sub>ċ5H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub></td>
<td>1400°C for 1 h</td>
</tr>
<tr>
<td>(heating rate: 10°C·min<sup>−1</sup>)</td>
</tr>
</tbody>
</table>
</table-wrap></p>
<p>Furthermore, commercial Bioglass® powder (NovaBone, USA) with particle size below 5 µm were also used for making separate scaffold batches.</p>
<p>From now on, the two types of Bioglass® powders will be distinguished as follows: the melt-derived Bioglass® sieved below 32 µm will be referred to as BG32, whereas the commercial one will be denoted as BG5.</p>
</sec>
<sec id="sec4-0885328211429193"><title>Glasses characterization</title>
<p>As-poured glasses underwent wide-angle (2θ within 10–70°) x-ray diffraction analysis (WA-XRD) using a X’Pert diffractometer operating at 40 kV and 30 mA (Bragg–Brentano camera geometry with Cu Kα incident radiation, incident wavelength λ = 1.5405 Å, step size Δ(2θ) = 0.02°, fixed counting time of 1 s per step).</p>
<p>Glass powders were silver-coated and their morphology was investigated by scanning electron microscopy (SEM, Philips 525 M; accelerating voltage = 15 kV).</p>
<p>The sintering process of glass powder compacts was monitored by hot-stage microscopy (HSM) (expert system solutions instrument) performed in air atmosphere to approximate the chemo-environmental conditions of the furnace chamber during the scaffold heat treatment. This analysis provides useful information for selecting the appropriate sintering temperature in order to obtain, at least ideally, scaffolds with well-densified trabeculae, high mechanical strength, and adequate porous content for bone tissue engineering applications. HSM allows the quantification of the shrinkage due to sintering by measuring the variation of specimen size during a controlled heating process (heating rate: 20°C·min<sup>−1</sup>). The samples for HSM analysis were prepared by manually pressing the glass powders using a small cylindrical mould (base diameter ∼1 mm, height ∼3 mm). Sample shrinkage at different temperatures, S<sub>glass,T</sub> (%), was assumed as isotropic and was estimated as
<disp-formula id="disp-formula1-0885328211429193"><label>(1)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math1-0885328211429193"><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mtext>glass</mml:mtext><mml:mo>,</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo/><mml:mo>(</mml:mo></mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula1-0885328211429193" xlink:href="10.1177_0885328211429193-eq1.tif"/></disp-formula>
where <italic>A<sub>0</sub></italic> is the area of the sample at room temperature and <italic>A<sub>T</sub></italic> is the sample area at the temperature <italic>T</italic> (°C).</p>
<p>Differential thermal analysis (DTA) of glass powders was carried out by using a DTA7 Perkin–Elmer instrument (temperature range: 50–1300°C; heating rate: 20°C·min<sup>−1</sup>). Pure alumina powder (Sigma–Aldrich) was used as a reference material and for baseline determination. The characteristic temperatures of glasses, that is, glass transition temperature (<italic>T<sub>g</sub></italic>), onset crystallization temperature (<italic>T<sub>x</sub></italic>), peak crystallization temperature (<italic>T<sub>c</sub></italic>), were assessed directly from the DTA plots. Melting temperature (<italic>T<sub>m</sub></italic>) of glasses was assessed by comparing HSM and DTA results (both analyses was performed according to analogous experimental conditions). It is worth anticipating that, when <italic>T<sub>m</sub></italic> is reached, the materials will be no longer the original glasses only, but glass-crystals composites (glass-ceramics) due to the nucleation of crystalline phases upon heating. Therefore, the use of expressions like ‘liquid point/liquid temperature of the material’ instead of ‘glass melting temperature’ would be more appropriate. However, in this work we will follow the common practice adopted in the scientific literature, which involves the use of the latter locution for sake of simplicity.</p>
</sec>
<sec id="sec5-0885328211429193"><title>Scaffolds fabrication</title>
<p>Sponge replication was chosen for scaffolding because it is an easy, low-cost and efficient method to obtain scaffolds with trabecular architecture closely mimicking that of the cancellous bone.<sup><xref ref-type="bibr" rid="bibr12-0885328211429193">12</xref>,<xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref></sup> Commercial polyurethane (PU) porous templates were coated with glass powder by impregnating polymer cubic blocks (15.0 × 15.0 × 15.0 mm<sup>3</sup>) in a water-based glass slurry (weight composition: 30% glass, 64% distilled water, 6% poly(vinyl alcohol) (PVA)).<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup> After PVA hydrolysis under continuous stirring at 80°C, the glass powder was dispersed in the solution and stirred for 0.5 h; the water eventually evaporated during PVA dissolution was re-added to the slurry. The sponge blocks were soaked into the glass slurry for 60 s, extracted and compressed (20 kPa for 1 s) up to 60% in thickness along the three spatial directions in order to homogeneously remove the exceeding slurry. This infiltration/compression cycle was repeated for three times; after that, a final cycle of impregnation alone without compression was performed. The samples were dried at room temperature for 6 h and thermally treated in order to remove the organic phase and to sinter the inorganic one, thereby obtaining macroporous glass-derived scaffolds. CEL2-derived scaffolds were all sintered at 1000°C for 3 h; as regards Bioglass®-derived scaffolds, the sintering time was always set at 3 h, but different sintering temperatures were experimented. For sake of clearness, the scaffolds batches sintered at different temperatures will be labeled by means of the acronym BG<italic>n-T</italic>, where <italic>n</italic> = 32 or 5 (µm) is the glass particle size and <italic>T</italic> (°C) is the sintering temperature.</p>
</sec>
<sec id="sec6-0885328211429193"><title>Scaffolds characterization</title>
<p>The scaffolds ground in powders underwent WA-XRD investigation (see the section ‘Glasses characterization’ before) to assess the presence of crystalline phases nucleated during the thermal treatment of sintering. Phase identification was performed by using X’Pert HighScore program equipped with PCPDFWIN database.</p>
<p>The scaffolds were silver-coated and analyzed from a morphological viewpoint by SEM (see the section ‘glasses characterization’ before) to assess the pores/struts size and shape.</p>
<p>The volumetric shrinkage S<sub>scaffold</sub> (%), due to the polymeric template removal and to the glass softening-sintering, was calculated as
<disp-formula id="disp-formula2-0885328211429193"><label>(2)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math2-0885328211429193"><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mtext>scaffold</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo/><mml:mo>(</mml:mo></mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula2-0885328211429193" xlink:href="10.1177_0885328211429193-eq2.tif"/></disp-formula>
where <italic>V</italic><sub>0</sub> is the volume of the glass-impregnated sponge before sintering and <italic>V</italic><sub>s</sub> is the volume of the final scaffold.</p>
<p>The porosity content P (%vol.) was calculated by means of geometrical weight-volume measurements as
<disp-formula id="disp-formula3-0885328211429193"><label>(3)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math3-0885328211429193"><mml:mrow><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo/><mml:mo>(</mml:mo></mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula3-0885328211429193" xlink:href="10.1177_0885328211429193-eq3.tif"/></disp-formula>
where <italic>ρ<sub>b</sub></italic> is the density of bulk material and <italic>ρ<sub>s</sub></italic> is the apparent density of the scaffold (weight/volume ratio).</p>
<p>Quantitative assessment of pores size distribution was carried out by image analysis (ImageJ software) on low-magnification SEM pictures of polished cross-sections of the scaffolds.</p>
<p>Scaffolds compressive strength was evaluated by means of crushing tests (MTS System Corp. apparatus, cross-head speed = 1 mm·min<sup>−1</sup>); the failure stress <italic>σ<sub>c</sub></italic> (MPa) was obtained as
<disp-formula id="disp-formula4-0885328211429193"><label>(4)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math4-0885328211429193"><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic alternate-form-of="disp-formula4-0885328211429193" xlink:href="10.1177_0885328211429193-eq4.tif"/></disp-formula>
where <italic>L<sub>M</sub></italic> (N) is the maximum compressive load registered during the test and <italic>A<sub>R</sub></italic> (mm<sup><xref ref-type="bibr" rid="bibr2-0885328211429193">2</xref></sup>) is the resistant area perpendicular to the load axis.</p>
<p><italic>In vitro</italic> tests were performed to assess scaffolds bioactivity by soaking the samples for 7 days in acellular simulated body fluid (SBF), prepared according to the protocol proposed by Kokubo and Takadama;<sup><xref ref-type="bibr" rid="bibr24-0885328211429193">24</xref></sup> a large part of the scientific community has recognized this assay as a valuable method for preliminary assessment of biomaterials bioactivity. Specifically, the scaffolds were soaked for different time frames in 30 mL of preheated SBF maintained at 37°C in an incubator (Bicasa). Every 48 h the samples were extracted from the solution, gently washed with distilled water and soaked in preheated fresh SBF. At the end of the experiment, the samples were gently washed with distilled water, dried at room temperature, silver-coated and investigated by SEM and energy dispersive spectroscopy (EDS; Philips Edax 9100) for compositional analysis.</p>
</sec>
</sec>
<sec id="sec7-0885328211429193" sec-type="results"><title>Results and discussion</title>
<sec id="sec8-0885328211429193"><title>Starting glasses</title>
<sec id="sec9-0885328211429193"><title>Glass powders morphology</title>
<p>commercial Bioglass® powders (BG5) are shown in <xref ref-type="fig" rid="fig1-0885328211429193">Figure 1(a)</xref>; BG5 particles are irregular with sharp edges and, being very fine (&lt;5 µm), showed the tendency to agglomerate forming aggregates.
<fig id="fig1-0885328211429193" position="float"><label>Figure 1.</label><caption><p>Glass powders morphology: (a) BG5 (magnification 2000×), (b) BG32 (magnification 1600×), (c) CEL2 (magnification 1500×).</p></caption><graphic xlink:href="10.1177_0885328211429193-fig1.tif"/>
</fig></p>
<p>Glass with the same composition of Bioglass® was also produced in our laboratories through a melting route; the final sieved glass particles (BG32) used for scaffolding are shown in <xref ref-type="fig" rid="fig1-0885328211429193">Figure 1(b)</xref>. An analogous processing schedule was adopted to produce CEL2 powders (<xref ref-type="fig" rid="fig1-0885328211429193">Figure 1(c)</xref>). The morphology of BG32 and CEL2 particles was nonspherical, irregular, and angular; a bimodal distribution of glass particles size can be qualitatively observed, since most of them were within 5–20 µm and relatively few particles were detected in the 20–32 µm range.</p>
</sec>
</sec>
<sec id="sec10-0885328211429193"><title>Thermal analyses</title>
<p>BG32, BG5, and CEL2 powders underwent HSM and DTA investigations, whose results are reported in Figures <xref ref-type="fig" rid="fig2-0885328211429193">2</xref>–<xref ref-type="fig" rid="fig7-0885328211429193">7</xref>. The characteristic temperatures of the glasses, assessed by DTA, are also reported in <xref ref-type="table" rid="table3-0885328211429193">Table 3</xref>. It is interesting to notice that particle size influences the position of the characteristic temperatures of Bioglass®. In fact, the characteristic temperatures of BG32 exhibit a slight shift toward higher values in comparison to BG5. This finding is in accordance to the results recently reported by Erol et al.,<sup><xref ref-type="bibr" rid="bibr25-0885328211429193">25</xref></sup> who demonstrated that, for the same glass, crystallization temperature (<italic>T<sub>x</sub></italic> and <italic>T<sub>c</sub></italic>) increase with the increase in the particle size.
<fig id="fig2-0885328211429193" position="float"><label>Figure 2.</label><caption><p>HSM images of a cylindrical BG32 sample at different characteristic temperatures during sintering.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig2.tif"/>
</fig>
<table-wrap id="table3-0885328211429193" position="float"><label>Table 3.</label><caption><p>DTA results (heating rate: 20°C min<sup>−1</sup>) and derived thermal parameters.</p></caption>
<graphic alternate-form-of="table3-0885328211429193" xlink:href="10.1177_0885328211429193-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Glass</th>
<th><italic>T<sub>g</sub></italic> (°C)</th>
<th><italic>T<sub>x</sub></italic> (°C)</th>
<th><italic>T<sub>c</sub></italic> (°C)</th>
<th><italic>T<sub>x</sub> – T<sub>g</sub></italic> (°C)</th>
<th><italic>K<sub>H</sub></italic></th>
</tr></thead>
<tbody align="left">
<tr>
<td>BG32</td>
<td>553</td>
<td>590</td>
<td>691</td>
<td>37</td>
<td>0.066</td>
</tr>
<tr>
<td>BG5</td>
<td>546</td>
<td>588</td>
<td>667</td>
<td>42</td>
<td>0.082</td>
</tr>
<tr>
<td>CEL2</td>
<td>552</td>
<td>652; 845</td>
<td>706; 873</td>
<td>100<sup><xref ref-type="table-fn" rid="table-fn1-0885328211429193">a</xref></sup></td>
<td>0.28<sup><xref ref-type="table-fn" rid="table-fn1-0885328211429193">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0885328211429193"><label>a</label><p><italic>T<sub>x</sub></italic><sub>1</sub> was considered for calculation.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>The reduction of samples dimensions (densification) during the sintering process can be clearly observed by looking at <xref ref-type="fig" rid="fig2-0885328211429193">Figures 2</xref>, <xref ref-type="fig" rid="fig4-0885328211429193">4</xref>, and <xref ref-type="fig" rid="fig6-0885328211429193">6</xref>. The specimens seem to maintain their cylindrical shape, that originates rectangular silhouettes, up to ∼1150°C, ∼1100°C, and ∼950°C for BG32, BG5, and CEL2, respectively. It is interesting to observe that CEL2 sample undergoes significant shrinkage in the 500–700°C range (<xref ref-type="fig" rid="fig6-0885328211429193">Figures 6</xref> and <xref ref-type="fig" rid="fig7-0885328211429193">7(a)</xref>). If temperature further increases, the glasses become softer and viscosity decreases, leading to distortion and final melting of the sample.
<fig id="fig3-0885328211429193" position="float"><label>Figure 3.</label><caption><p>Thermal analyses on BG32: (a) shrinkage variation as a function of temperature during HSM and (b) DTA plot.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig3.tif"/>
</fig>
<fig id="fig4-0885328211429193" position="float"><label>Figure 4.</label><caption><p>HSM images of a cylindrical BG5 sample at different characteristic temperatures during sintering.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig4.tif"/>
</fig>
<fig id="fig5-0885328211429193" position="float"><label>Figure 5.</label><caption><p>Thermal analyses on BG5: (a) shrinkage variation as a function of temperature during HSM and (b) DTA plot.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig5.tif"/>
</fig>
<fig id="fig6-0885328211429193" position="float"><label>Figure 6.</label><caption><p>HSM images of a cylindrical CEL2 sample at different characteristic temperatures during sintering.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig6.tif"/>
</fig>
<fig id="fig7-0885328211429193" position="float"><label>Figure 7.</label><caption><p>Thermal analyses on CEL2: (a) shrinkage variation as a function of temperature during HSM and (b) DTA plot.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig7.tif"/>
</fig>
</p>
<p>A quantitative evaluation of the variations of glasses shrinkage depending on the sintering temperature can be derived from the curves plotted in <xref ref-type="fig" rid="fig3-0885328211429193">Figures 3(a)</xref>, <xref ref-type="fig" rid="fig5-0885328211429193">5(a)</xref>, and <xref ref-type="fig" rid="fig7-0885328211429193">7(a)</xref>. As clearly evident from the HSM curves reported in <xref ref-type="fig" rid="fig3-0885328211429193">Figures 3(a)</xref> and <xref ref-type="fig" rid="fig5-0885328211429193">5(a)</xref>, the thermal behavior of BG32 and BG5 powders is different. BG32 powder compact exhibits no evident densification steps and seems to keep its unchanged shape up to <italic>T</italic><sub>1</sub> ≈ 1150°C (<xref ref-type="fig" rid="fig2-0885328211429193">Figure 2</xref>), when the material begins to melt. Increasing the temperature above <italic>T</italic><sub>1</sub>, the material becomes softer and the viscosity significantly decreases, thereby leading to a prompt reduction of the sample silhouette (<xref ref-type="fig" rid="fig3-0885328211429193">Figure 3</xref>), which corresponds to the melting of the glass. BG32 seems to exhibit no significant stage of densification before melting (<xref ref-type="fig" rid="fig3-0885328211429193">Figure 3(a)</xref>): in fact, it was estimated that S<sub>BG32,1150</sub> ≈ 2 %.
</p>
<p>On the contrary, as clearly evident in <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5(a)</xref>, BG5 exhibits a 2-step densification behavior. This observation is consistent with the findings reported by Bretcanu et al.<sup><xref ref-type="bibr" rid="bibr26-0885328211429193">26</xref></sup> The first step of densification (ΔS<sub>1</sub>) occurs between <italic>T</italic><sub>1</sub> ≈ 550°C and <italic>T</italic><sub>2</sub> ≈ 615°C: it begins shortly after the <italic>T<sub>g</sub></italic> is reached (<xref ref-type="table" rid="table3-0885328211429193">Table 3</xref>), that is, when viscous flow sintering starts. From a quantitative viewpoint, we estimated S<sub>BG5,615</sub> ≈ 6%. As shown in <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5</xref>, crystallization of BG5 particles begins before <italic>T</italic><sub>2</sub> and occurs up to ∼750°C; hence, the material will be highly crystalline before the second stage of densification (ΔS<sub>2</sub>) takes place above <italic>T</italic><sub>3</sub> ≈ 900°C, as also demonstrated by other authors.<sup><xref ref-type="bibr" rid="bibr26-0885328211429193">26</xref>,<xref ref-type="bibr" rid="bibr27-0885328211429193">27</xref></sup> From a theoretical viewpoint, the whole plateau (<italic>T</italic><sub>3</sub> – <italic>T</italic><sub>2</sub>), observed between the two stages of shrinkage in <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5(a)</xref>, should correspond to the crystallization process, during which the viscosity increases and viscous flow sintering is inhibited. If temperature increases again, viscosity decreases and the second stage of shrinkage occurs. Estimating <italic>T</italic><sub>4</sub> ≈ 1100°C as the end temperature of the second stage of BG5 densification or, alternatively, as the onset temperature of BG5 melting, we calculated ΔS<sub>2</sub> ≈ 20%; therefore, the total shrinkage of BG5 up to <italic>T</italic><sub>4</sub> was S<sub>BG5,1100</sub> ≈ 26%.</p>
<p>Finally, <xref ref-type="fig" rid="fig7-0885328211429193">Figure 7(a)</xref> reveals that CEL2 exhibited a 1-step densification behavior (Δ<italic>S</italic><sub>tot</sub>); specifically, densification begins at <italic>T</italic><sub>1</sub> ≈ <italic>T<sub>g</sub></italic> (beginning of viscous flow sintering) and is fully completed when crystallization starts (<italic>T</italic><sub>2</sub> ≈ <italic>T<sub>x</sub></italic><sub>1</sub>). We estimated that the shrinkage up to <italic>T</italic><sub>2</sub> was Δ<italic>S</italic><sub>tot</sub> = S<sub>BG5,650</sub> ≈ 25 %. CEL2 specimen started to expand at <italic>T</italic><sub>3</sub> ≈ 925°C, and the melting onset occurred at <italic>T</italic><sub>4</sub> ≈ 1000°C.</p>
<p>Relevant expansion of CEL2 above <italic>T</italic><sub>3</sub> (<xref ref-type="fig" rid="fig6-0885328211429193">Figures 6</xref> and <xref ref-type="fig" rid="fig7-0885328211429193">7(a)</xref>) might be related to the crystallization of the second phase Ca<sub>2</sub>Mg(Si<sub>2</sub>O<sub>7</sub>)<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup> (see also the section ‘structural analysis’ later), considering that full densification was already achieved. This behavior was not observed in Bioglass®, as its expansion at high temperature due to crystallization is balanced by shrinkage. This issue was discussed in an interesting work by Huang et al.,<sup><xref ref-type="bibr" rid="bibr27-0885328211429193">27</xref></sup> who investigated the behavior of commercial Bioglass® powders – i.e. the BG5 used in this work – upon heating: up to 900°C, sintering is fully suppressed by crystallization, but, if temperature is further increased, shrinkage and densification can significantly occur. These findings are in good agreement with the results reported in the present work.</p>
</sec>
<sec id="sec11-0885328211429193"><title>Sintering and crystallization of the glasses: Quantitative considerations</title>
<p>Glass stability against crystallization upon heating can be evaluated, from a quantitative viewpoint, by considering the difference <italic>T<sub>x</sub></italic> – <italic>T<sub>g</sub></italic> estimated from DTA plots (<xref ref-type="table" rid="table3-0885328211429193">Table 3</xref>). This parameter indicates the tendency toward crystallization of the glass composition, as a greater difference reveals a lower tendency to crystallization, that is, a greater stability of the materials in its glassy state upon heating.</p>
<p>Hruby<sup><xref ref-type="bibr" rid="bibr28-0885328211429193">28</xref></sup> proposed another parameter, <italic>K<sub>H</sub></italic>, defined as
<disp-formula id="disp-formula5-0885328211429193"><label>(5)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math5-0885328211429193"><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic alternate-form-of="disp-formula5-0885328211429193" xlink:href="10.1177_0885328211429193-eq5.tif"/></disp-formula>
that can be used to measure glass stability. According to Hruby, the larger the <italic>K<sub>H</sub></italic> of a certain glass, the greater its stability against crystallization upon heating. Therefore, as shown in <xref ref-type="table" rid="table3-0885328211429193">Table 3</xref>, Bioglass® revealed a higher crystallization ability in comparison to CEL2 and, therefore, a lower stability in glass form.</p>
<p>It is well known that viscous flow sintering of glass particles can effectively occur when their surface tension is high and the viscosity is low, that is, when the glass shows its lower viscosity, without, ideally, any crystallization process in action.<sup><xref ref-type="bibr" rid="bibr29-0885328211429193">29</xref>,<xref ref-type="bibr" rid="bibr30-0885328211429193">30</xref></sup> Recently, Lara et al.<sup><xref ref-type="bibr" rid="bibr31-0885328211429193">31</xref></sup> introduced a new parameter, <italic>S<sub>c</sub></italic> (sinterability), which estimates the competition between glass sintering and crystallization of glass powders during heating. It is defined as <italic>S<sub>c</sub></italic> = <italic>T<sub>x</sub> – T</italic><sub>MS</sub>, where <italic>T</italic><sub>MS</sub> is the temperature of maximum shrinkage determined from HSM. As explained by Lara et al.,<sup><xref ref-type="bibr" rid="bibr31-0885328211429193">31</xref></sup> the difference between starting crystallization and maximum shrinkage temperatures is a measure of the ability of sintering versus crystallization: the greater the <italic>S<sub>c</sub></italic>, the more independent are the kinetics of the two processes.</p>
<p>Furthermore, we propose a general rule for the interpretation of <italic>S<sub>c</sub></italic>: if <italic>S<sub>c</sub></italic> &lt; 0, only partial densification is achieved before crystallization begins; otherwise, if <italic>S<sub>c</sub></italic> ≥ 0, full densification occurs prior to crystallization. Therefore, higher S<sub>c</sub> are related to higher final densities, which indicated a better sintering behavior involving a higher densification of the final sample.</p>
<p>In this work, it is worth carefully considering the meaning of <italic>S<sub>c</sub></italic> for each glass. As regards BG32, the glass powder compact undergoes no shrinkage up to <italic>T</italic><sub>1</sub> ≈ 1150°C, when the material begins to melt (Figures <xref ref-type="fig" rid="fig2-0885328211429193">2</xref> and <xref ref-type="fig" rid="fig3-0885328211429193">3</xref>); therefore, we can assume as a limit <italic>T</italic><sub>MS</sub> = <italic>T</italic><sub>1</sub>, and, accordingly, we have <italic>S<sub>c</sub></italic> &lt; 0. A similar situation can be observed for BG5: crystallization of the glass occurs prior to significant densification, as the major step of shrinkage (Δ<italic>S</italic><sub>2</sub>) takes place above 900°C. By looking at <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5</xref>, we can assume as a limit <italic>T</italic><sub>MS</sub> = <italic>T</italic><sub>4</sub>; hence, also for BG5 we have <italic>S<sub>c</sub></italic> &lt; 0.</p>
<p>The situation is different for CEL2, as crystallization begins when the maximum shrinkage is reached. From <xref ref-type="fig" rid="fig7-0885328211429193">Figure 7(a)</xref> we can assume that <italic>T</italic><sub>MS</sub> = <italic>T</italic><sub>2</sub> ≈ <italic>T<sub>x</sub></italic>; hence, we have <italic>S<sub>c</sub></italic> ≈ 0. Therefore, CEL2 exhibits a higher sinterability than Bioglass®, which eventually will ensue in a better densification of the material.</p>
</sec>
<sec id="sec12-0885328211429193"><title>Remarks on the selection of the sintering temperature from thermal analysis data</title>
<p>Data from thermal analyses are very useful to guide researchers in selecting the ‘optimal’ sintering temperature for fabricating scaffolds, in order to obtain a good compromise between densification, required to strengthen the struts of the final porous body, and pore content, which should be above 50 %vol. to promote cell colonization, implant vascularization and bone in-growth.<sup><xref ref-type="bibr" rid="bibr19-0885328211429193">19</xref></sup> However, it should be underlined that the sintering process of scaffolds obtained by sponge replication, like those fabricated in this work, is quite different from the sintering of compacts of glass powders, like those used for HSM. First, glass-impregnated PU sponges exhibit large macropores due to the 3-D architecture of the polymer template, whereas the pores detectable in compacts of glass powders are attributable to small intraparticulate voids. Furthermore, during thermal treatment of the glass-coated polymer we assist not only to densification/crystallization of glass particles, but also to the burning-out of the polymer template, which may eventually ensue in significant additional contraction of the structure on its own weight. From a theoretical viewpoint, HSM of a glass-impregnated sponge would give more precise information to select the optimal sintering temperature for scaffolding, but such a test is not feasible due to obvious working difficulties such as cutting and impregnation of very small sponge pieces suitable to be introduced in the HSM equipment.</p>
<p>In the authors’ view, HSM on glass powder compacts is therefore useful to understand glass behavior upon heating and can provide a range of potentially suitable temperatures for sintering sponge-replicated scaffolds, but the actually ‘optimal’ sintering temperature can be found only through a fine evaluation involving the factual fabrication of test specimens, as we did in this work. As a preliminary and general criterion, if a wholly glass material is desired after thermal treatment, sintering temperature(s) should be chosen in the range between the maximum densification and the onset of crystallization. However, if glass–ceramic structures are required – for instance, for high-strength applications as in the case of biomedical scaffolds – or if crystallization occurs before densification is completed (in this sense, the behavior of BG5, reported in <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5</xref>, is emblematic), temperatures between maximum shrinkage and melting onset are usually considered.</p>
</sec>
<sec id="sec13-0885328211429193"><title>Glass-derived scaffolds</title>
<p>The processing schedule developed by the authors for fabricating GC-CEL2 scaffolds<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup> was adopted in this work to manufacture Bioglass®-derived scaffolds. The features of the commercial open-cell PU sponge used as a sacrificial template were described elsewhere.<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup></p>
<p><italic>Structural analysis:</italic> as-melt BG32 is a completely amorphous material: only a broad halo and no diffraction peaks are visible in the corresponding XRD pattern (<xref ref-type="fig" rid="fig8-0885328211429193">Figure 8</xref>). XRD plots of GC-BG32 scaffolds sintered at different temperatures and ground in powder for diffraction analysis are also reported in <xref ref-type="fig" rid="fig8-0885328211429193">Figure 8</xref>. The main crystalline phase was identified as Na<sub>2</sub>CaSi<sub>2</sub>O<sub>6</sub>, as already reported by other authors.<sup><xref ref-type="bibr" rid="bibr32-0885328211429193">32</xref>–<xref ref-type="bibr" rid="bibr34-0885328211429193">34</xref></sup> A secondary phase corresponding to Na<sub>2</sub>Ca<sub>4</sub>(PO<sub>4</sub>)<sub>2</sub>SiO<sub>4</sub> was also identified, as expected from the literature;<sup><xref ref-type="bibr" rid="bibr26-0885328211429193">26</xref>,<xref ref-type="bibr" rid="bibr33-0885328211429193">33</xref>,<xref ref-type="bibr" rid="bibr34-0885328211429193">34</xref></sup> this phase was not always detected and reported in the literature due to the difficult interpretation of XRD data.
<fig id="fig8-0885328211429193" position="float"><label>Figure 8.</label><caption><p>WA-XRD patterns of Bioglass® powder and Bioglass®-derived scaffolds (GC-BG32) ground in powders.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig8.tif"/>
</fig></p>
<p>For sake of discussion, it is worth mentioning that there is no unanimity in the literature about the identification of the major phase of GC-Bioglass®. Over the years, different research groups suggested two possible options (both of them are sodium-calcium silicates): Na<sub>2</sub>Ca<sub>2</sub>Si<sub>3</sub>O<sub>9</sub><sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref>,<xref ref-type="bibr" rid="bibr18-0885328211429193">18</xref>,<xref ref-type="bibr" rid="bibr26-0885328211429193">26</xref></sup> and Na<sub>2</sub>CaSi<sub>2</sub>O<sub>6</sub>.<sup><xref ref-type="bibr" rid="bibr32-0885328211429193">32</xref>–<xref ref-type="bibr" rid="bibr34-0885328211429193">34</xref></sup> Recently, Bellucci et al.<sup><xref ref-type="bibr" rid="bibr35-0885328211429193">35</xref></sup> hypothesized coexistence between the two phases. In this work, we confirm that the phase assignment already suggested by Lin et al.<sup><xref ref-type="bibr" rid="bibr32-0885328211429193">32</xref></sup> and Lefebvre et al.<sup><xref ref-type="bibr" rid="bibr33-0885328211429193">33</xref>,<xref ref-type="bibr" rid="bibr34-0885328211429193">34</xref></sup> is the most likely.</p>
<p>XRD pattern of GC-CEL2 is not reported, as the identification of the crystalline phases (Na<sub>4</sub>Ca<sub>4</sub>(Si<sub>6</sub>O<sub>18</sub>) and Ca<sub>2</sub>Mg(Si<sub>2</sub>O<sub>7</sub>)) was discussed elsewhere in detail.<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup></p>
<sec id="sec14-0885328211429193"><title>Architecture and morphology</title>
<p>first, noncommercial BG32 powders were used as a starting material in the sponge replication process. Different sintering temperatures were adopted, ranging from 1000 to 1180°C; sintering temperatures higher than 1180°C led to scaffold collapse. A comparison of the different sintering results is shown in <xref ref-type="fig" rid="fig9-0885328211429193">Figure 9</xref>. After sintering, a glass-ceramic replica of the starting polymer template, closely mimicking the trabecular architecture of natural cancellous bone with most of pores in the 100–600 µm range, is successfully achieved in all cases. However, it cannot be ignored that unsatisfactory sintering results were obtained at treatment temperatures up to 1150°C (<xref ref-type="fig" rid="fig9-0885328211429193">Figures 9(a)</xref>–(<xref ref-type="fig" rid="fig9-0885328211429193">d</xref>)). In fact, sponge architecture was faithfully replicated, but scaffold trabeculae are not sufficiently densified and the original glass particles with sharp edges can still be observed. These scaffolds were characterized by a noticeable brittleness, were susceptible of damage when handled and, therefore, were mechanically unsuitable for possible clinical use. In <xref ref-type="fig" rid="fig9-0885328211429193">Figure 9(d)</xref> a hollow central region in scaffold struts (white circle), corresponding to the trace of the PU template removed by thermal treatment, is clearly distinguishable. Chen et al. in 2006<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref><xref ref-type="bibr" rid="bibr6-0885328211429193">6</xref></sup> and Bretcanu et al. in 2007<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref><xref ref-type="bibr" rid="bibr7-0885328211429193">7</xref></sup> also reported this unwanted feature as peculiar for Bioglass®-derived glass-ceramic scaffolds. By increasing the temperature above 1150°C, viscosity decreases and viscous flow sintering is enhanced. Scaffold trabeculae progressively densify, thereby eventually leading to a typical round-shaped and relatively smooth texture of the strut (<xref ref-type="fig" rid="fig9-0885328211429193">Figures 9(h)</xref> and (<xref ref-type="fig" rid="fig9-0885328211429193">i</xref>)), on the surface of which the sharp and well-defined original glass particles are no longer distinguishable. It is interesting to notice that GC-BG32-1180 scaffolds maintained their cubic form without distortion (<xref ref-type="fig" rid="fig9-0885328211429193">Figure 9(g)</xref>), despite the significant volume shrinkage of the macrostructure (&gt; 60%, as reported in <xref ref-type="table" rid="table4-0885328211429193">Table 4</xref>). This finding is very important in view of the possible clinical use of the scaffold, if bone substitutes of complex shape are needed for specific bone regeneration applications.
<fig id="fig9-0885328211429193" position="float"><label>Figure 9.</label><caption><p>GC-BG32 scaffolds architecture: (a) GC-BG32-1000 scaffold (magnification 200×); (b) GC-BG32-1050 scaffold (magnification 300×); (c) GC-BG32-1100 scaffold (magnification 300×); (d) GC-BG32-1150 scaffold (magnification 300×); (e) GC-BG32-1160 scaffold (magnification 400×); (f) GC-BG32-1170 scaffold (magnification 300×); (g-i) GC-BG32-1180 scaffold (magnification 400× and 800× for (g) and (h), respectively).</p></caption><graphic xlink:href="10.1177_0885328211429193-fig9.tif"/>
</fig>
<table-wrap id="table4-0885328211429193" position="float"><label>Table 4.</label><caption><p>Features of the produced scaffolds (five samples were tested for each scaffold batch).</p></caption>
<graphic alternate-form-of="table4-0885328211429193" xlink:href="10.1177_0885328211429193-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Scaffold</th>
<th><italic>S</italic><sub>scaffold</sub> (%)</th>
<th><italic>P</italic> (%vol.)</th>
<th>σ<italic><sub>c</sub></italic> (MPa)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>GC-BG32-1100</td>
<td>20.9 ± 4.2</td>
<td>83.0 ± 1.0</td>
<td>0.2 ± 0.1</td>
</tr>
<tr>
<td>GC-BG32-1180</td>
<td>61.6 ± 5.3</td>
<td>70.7 ± 3.3</td>
<td>1.3 ± 0.8</td>
</tr>
<tr>
<td>GC-BG5-1100</td>
<td>60.9 ± 2.4</td>
<td>69.3 ± 2.3</td>
<td>2.5 ± 0.5</td>
</tr>
<tr>
<td>GC-CEL2</td>
<td>61.9 ± 4.8</td>
<td>66.4 ± 2.0</td>
<td>4.5 ± 0.9</td>
</tr>
</tbody>
</table>
</table-wrap></p>
<p>The same processing method used to produce GC-BG32 scaffolds was also adopted to manufacture GC-BG5 scaffolds (<xref ref-type="fig" rid="fig10-0885328211429193">Figure 10</xref>). On the basis of the shrinkage observed in the HSM (<xref ref-type="fig" rid="fig4-0885328211429193">Figures 4</xref> and <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5(a)</xref>), the sintering temperature was first set at 1100°C, which corresponds to the onset of BG5 powders melting (<italic>T</italic><sub>4</sub> of <xref ref-type="fig" rid="fig5-0885328211429193">Figure 5(a)</xref>). After sintering, a glass-ceramic replica of the polymer template was obtained: scaffold struts appeared to be well densified (<xref ref-type="fig" rid="fig10-0885328211429193">Figure 10(b)</xref>) and, from a qualitative viewpoint, the scaffold was mechanically competent and could be handled without undergoing any damage. No evidence of template-derived cavities inside the struts were detected (see the white circles in <xref ref-type="fig" rid="fig10-0885328211429193">Figure 10(a)</xref>). Thermal treatment at temperature higher than 1100°C caused scaffold collapse: due to temperature increase, glass viscosity decreases, and the scaffold porous structure readily deforms under its own weight.
<fig id="fig10-0885328211429193" position="float"><label>Figure 10.</label><caption><p>SEM micrographs of GC-BG5-1100 scaffold architecture at (a) low magnification (300×) and (b) high magnification (1200×).</p></caption><graphic xlink:href="10.1177_0885328211429193-fig10.tif"/>
</fig></p>
<p>The architectural features of GC-CEL2 scaffolds were extensively presented and discussed elsewhere;<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref></sup> for sake of completeness, a polished cross-section and a detail of pore network are shown in <xref ref-type="fig" rid="fig11-0885328211429193">Figure 11</xref>.
<fig id="fig11-0885328211429193" position="float"><label>Figure 11.</label><caption><p>GC-CEL2 scaffolds architecture: (a) polished cross-section (magnification 40×) and (b) 3-D strut network (magnification 200×).</p></caption><graphic xlink:href="10.1177_0885328211429193-fig11.tif"/>
</fig></p>
<p>It is worth underlining that the most promising scaffolds, that is, the best densified ones, all exhibit an adequate pore content (&gt;50 %vol.<sup><xref ref-type="bibr" rid="bibr19-0885328211429193">19</xref></sup>) for bone regeneration applications, as reported in <xref ref-type="table" rid="table4-0885328211429193">Table 4</xref>. The trabecular network of interconnected macropores (size within 100–600 µm) is expected to allow cell colonization and migration in the whole scaffold structure (including its inner region), bone tissue in-growth and <italic>in vivo</italic> blood vessel access.</p>
<p>Furthermore, pores size distribution was investigated by means of image analysis (ImageJ program) performed on polished cross sections of the scaffolds acquired by SEM. The pores were approximated as circular by the software; hence, the equivalent pore diameter <italic>D</italic><sub>eq</sub> (µm) was calculated as <inline-formula id="ilm1-0885328211429193"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="mml-math1-0885328211429193"><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>eq</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msqrt><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:msqrt></mml:mrow></mml:math></inline-formula>, where <italic>A<sub>p</sub></italic> (µm<sup>2</sup>) is the pore area measured by the program. An example of pores size distribution of the most significant scaffolds batches is reported in <xref ref-type="fig" rid="fig12-0885328211429193">Figure 12</xref>; only large macropores (50–1000 µm) were considered for better readability of the bar chart. It should be carefully taken into account that cells play a key role in implanted porous biomaterials; in the light of this consideration, the importance of pores at the upper macroscale is really crucial to promote the effective ossteointegration of the scaffold. As underlined in the literature,<sup><xref ref-type="bibr" rid="bibr12-0885328211429193">12</xref>,<xref ref-type="bibr" rid="bibr19-0885328211429193">19</xref></sup> interconnected porosity above 10 µm is generally useful for cells penetration; more specifically, pores ranging within 100–600 µm allow bone in-growth and blood vessel access, and pores above 600 µm can also lower Young’s modulus of the implant thereby reducing the stress-shielding phenomenon and provide facilities for scaffold fixation to host bone by surgical wires. As shown in <xref ref-type="fig" rid="fig12-0885328211429193">Figure 12</xref>, for all the three scaffolds batches ∼50% or more of pores ranged within 100–1000 µm and, furthermore, were related to above 90% of the total pores area; accordingly, these macropores are large enough to potentially allow bone in-growth and vascularization after <italic>in vivo</italic> implantation of the scaffolds.
<fig id="fig12-0885328211429193" position="float"><label>Figure 12.</label><caption><p>Pores size distribution resulting from image analysis on polished GC-BG32-1180, GC-BG5-1100 and GC-CEL2 scaffolds cross-sections.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig12.tif"/>
</fig></p>
</sec>
<sec id="sec15-0885328211429193"><title>Mechanical strength</title>
<p><xref ref-type="table" rid="table4-0885328211429193">Table 4</xref> collects the results of compressive tests performed on the most significant scaffolds batches produced in this work. As regards GC-BG32 scaffolds, it is interesting to observe that an increment of sintering temperature from 1100°C to 1180°C involves an increase of mechanical strength by a factor ∼6.5. This can be essentially attributed to two reasons: (i) sintering at higher temperature is accompanied to a higher volumetric shrinkage of the scaffold, involving a lower pore content in the final porous body; (ii) by adopting a higher sintering temperature, an enhanced densification of scaffold trabeculae is achieved, as can be immediately observed by comparing <xref ref-type="fig" rid="fig9-0885328211429193">Figure 9(c)</xref> (GC-BG32-1100 scaffold) with <xref ref-type="fig" rid="fig9-0885328211429193">Figure 9(i)</xref> (GC-BG32-1180 scaffold).</p>
<p>Sintering of Bioglass®-derived (starting powders &lt; 5 µm) glass-ceramic scaffolds at 1100°C was already reported by Bretcanu et al.,<sup><xref ref-type="bibr" rid="bibr17-0885328211429193">17</xref></sup> who obtained a compressive strength of ∼0.2 MPa: this value is more than ten times lower than that reported in this work (2.5 MPa). This remarkable discrepancy can be explained considering that the method of PU sponge impregnation is different (one cycle of impregnation for the scaffolds prepared by Bretcanu et al.<sup><xref ref-type="bibr" rid="bibr17-0885328211429193">17</xref></sup> versus four cycles adopted in the present work), as well as the sintering time (1 h vs. 3 h). Optimization of scaffold impregnation process and sintering treatment have now led to better densified struts, which ensues in a strengthened scaffold structure. Furthermore, it cannot be ignored that the scaffolds produced by Bretcanu et al.<sup><xref ref-type="bibr" rid="bibr17-0885328211429193">17</xref></sup> exhibited a hollow central region in their struts, whereas no evidence of this tricky feature was noticed in the GC-BG-1100 scaffolds prepared in this work (<xref ref-type="fig" rid="fig10-0885328211429193">Figure 10(b)</xref>).</p>
<p>It is also interesting to compare the properties of GC-BG32-1180 and GC-BG5-1100 scaffolds: as reported in <xref ref-type="table" rid="table4-0885328211429193">Table 4</xref>, both exhibit analogous volumetric shrinkage and pore content, but the compressive strength of GC-BG5-1100 scaffolds is twofold than that of GC-BG32-1180 ones. This can be attributable to a better coating of PU template and a higher homogeneity obtained by the very fine commercial Bioglass® particles (&lt; 5 µm) in comparison to non-commercial ones (&lt; 32 µm). It is worth further remarking that BG32 particles undergo very slight densification upon heating (<xref ref-type="fig" rid="fig3-0885328211429193">Figure 3(a)</xref>), which should involve the formation of ‘weak’ struts in the final scaffold.</p>
<p>The significantly higher mechanical strength of GC-CEL2 scaffolds in comparison to that of Bioglass®-derived ones (<xref ref-type="table" rid="table4-0885328211429193">Table 4</xref>) cannot be attributed only to a slight decrease of pore content, which is almost negligible, but mainly to a better densification of the GC-CEL2 scaffold trabeculae. In fact, as previously discussed in the section ‘Sintering and crystallization of the glasses: quantitative considerations’, CEL2 exhibits a significantly higher Hruby parameter (<xref ref-type="table" rid="table3-0885328211429193">Table 3</xref>) as well as a greater sinterability in comparison to Bioglass®, which eventually leads to scaffolds with well-densified and strengthened struts.</p>
<p>The different compressive strength of the scaffolds can be also dependent on the intrinsic characteristics of the material constituting the porous body – for instance, different mechanical strength and hardness of the crystalline phases detected in sintered GC-CEL2 and GC-Bioglass®. Definite, quantitative assessment of the relationship between the mechanical properties of the crystalline phases and those of the scaffolds – i.e., the correlation between macro- and micromechanics of the scaffolds – goes beyond the aim of this work. However, we wish to present the following, simple reasoning: in principle, higher the density of a material, higher is its mechanical strength; therefore, we can compare the densities of the crystalline phases detected by XRD in GC-CEL2 and GC-Bioglass® scaffolds. By looking at the data available in the PDF database, we observed that the densities of Na<sub>2</sub>CaSi<sub>2</sub>O<sub>6</sub> (major crystalline phase of GC-Bioglass®), Na<sub>4</sub>Ca<sub>4</sub>(Si<sub>6</sub>O<sub>18</sub>) and Ca<sub>2</sub>Mg(Si<sub>2</sub>O<sub>7</sub>) (both found in GC-CEL2) are ∼2.83, ∼2.85, and ∼2.95 g·cm<sup>−3</sup>, respectively. The densities of GC-CEL2 crystalline phases are higher in comparison to that of GC-Bioglass® phase, and the mechanical strength of the two types of scaffolds are affected accordingly.</p>
<p>It is worth highlighting that the GC-BG32 and GC-BG5 scaffolds produced in this work are the first Bioglass®-derived porous bodies able to exhibit suitable mechanical properties and porous architecture for really deeming a final clinical use of them. Foam-derived GC-Bioglass® scaffolds previously described in the literature, even though exhibiting suitable pore content for potential bone tissue in-growth and excellent bioactivity, were too brittle to be safely implanted <italic>in vivo.</italic><sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref>,<xref ref-type="bibr" rid="bibr17-0885328211429193">17</xref></sup> Fabrication of GC-Bioglass® scaffolds with higher strength (up to 7 MPa) was reported by Wu et al.,<sup><xref ref-type="bibr" rid="bibr18-0885328211429193">18</xref></sup> but they were characterized by a poorly interconnected pore network and a too low pore content (∼45 %vol.) to be actually suggested as suitable bone grafts. <xref ref-type="table" rid="table5-0885328211429193">Table 5</xref> provides an useful comparison between the properties of the scaffolds produced in this work and those of some glass/glass-ceramic scaffolds, all fabricated by sponge replication, proposed in the literature.<sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref>,<xref ref-type="bibr" rid="bibr17-0885328211429193">17</xref>,<xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref>,<xref ref-type="bibr" rid="bibr23-0885328211429193">23</xref>,<xref ref-type="bibr" rid="bibr36-0885328211429193">36</xref>–<xref ref-type="bibr" rid="bibr43-0885328211429193">43</xref></sup> It is worth underlining that all these scaffolds exhibit very attractive architectural features (e.g., adequate pore content, bone-like trabecular structure) and bioactive properties, but only a subset of them<sup><xref ref-type="bibr" rid="bibr21-0885328211429193">21</xref>,<xref ref-type="bibr" rid="bibr36-0885328211429193">36</xref>–<xref ref-type="bibr" rid="bibr42-0885328211429193">42</xref></sup> possesses mechanical strength comparable to that of cancellous bone (2–12 MPa<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref></sup>).
<table-wrap id="table5-0885328211429193" position="float"><label>Table 5.</label><caption><p>Overview of porosity and mechanical properties of select bone tissue engineering glass-derived scaffolds fabricated through sponge replication.</p></caption>
<graphic alternate-form-of="table5-0885328211429193" xlink:href="10.1177_0885328211429193-table5.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Scaffold material<sup><xref ref-type="table-fn" rid="table-fn2-0885328211429193">a.</xref><xref ref-type="table-fn" rid="table-fn3-0885328211429193">b</xref></sup></th>
<th>Remarks</th>
<th>Porosity (%vol.)</th>
<th>Compressive strength (MPa)</th>
<th>References</th>
</tr></thead>
<tbody align="left">
<tr>
<td rowspan="4">GC-Bioglass®</td>
<td>Starting glass powders size &lt; 5 µm (commercial product). Sintering condition: 1000°C/1 h</td>
<td>89–92</td>
<td>0.27–0.42</td>
<td>[16]</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 5 µm (commercial product). Sintering condition: 1100°C/1 h</td>
<td>79–85</td>
<td>∼0.2</td>
<td>[17]</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 32 µm (non-commercial product). Sintering conditions: 1100°C/3 h; 1180°C/3 h</td>
<td>70.7–83.0</td>
<td>0.2–1.3</td>
<td>This work</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 5 µm (commercial product). Sintering condition: 1100°C/3 h</td>
<td>69.3</td>
<td>2.5</td>
<td>This work</td>
</tr>
<tr>
<td>Poly(3-hydroxybutyrate)-coated GC-Bioglass®</td>
<td>Composite scaffold</td>
<td>79–85</td>
<td>0.3–1.5</td>
<td>[17]</td>
</tr>
<tr>
<td rowspan="4">GC-CEL2</td>
<td rowspan="2">Starting glass powders size &lt; 32 µm. Sintering conditions: 950°C/3 h; 1000°C/3 h</td>
<td>55–75</td>
<td>1.0–5.5</td>
<td>[21, 23, 36]</td>
</tr>
<tr>
<td>∼66.4</td>
<td>∼4.5</td>
<td>This work</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 32 µm. Sintering conditions: 1000°C/3 h. Totally porous scaffold with gradient of porosity</td>
<td>∼64.6</td>
<td>∼1.9</td>
<td>[37]</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 32 µm. Sintering conditions: 1000°C/3 h. Graded scaffold mimicking the cancellous/cortical bone system (sponge replication was used to fabricate the porous region)</td>
<td>∼53.0</td>
<td>∼9.7</td>
<td>[37]</td>
</tr>
<tr>
<td rowspan="3">GC-FaGC</td>
<td>FaGC composition (%mol.): 50SiO<sub>2</sub>-18CaO-7Na<sub>2</sub>O-6P<sub>2</sub>O<sub>5</sub>-7K<sub>2</sub>O-3MgO-9CaF<sub>2</sub></td>
<td rowspan="3">∼75</td>
<td rowspan="3">∼2</td>
<td rowspan="3">[38, 39]</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 32 µm</td>
</tr>
<tr>
<td>Sintering condition: 700°C/1 h</td>
</tr>
<tr>
<td rowspan="3">13-93</td>
<td>13-93 composition (%mol.): 6Na<sub>2</sub>O-12K<sub>2</sub>O-5MgO-20CaO-53SiO<sub>2</sub>-4P<sub>2</sub>O<sub>5</sub></td>
<td rowspan="3">∼85</td>
<td rowspan="3">∼11</td>
<td rowspan="3">[40]</td>
</tr>
<tr>
<td>Starting glass powders size: 5-10 µm</td>
</tr>
<tr>
<td>Sintering condition: 700°C/1 h</td>
</tr>
<tr>
<td rowspan="3">13-93B2</td>
<td>13-93B2 composition (%mol.): 6Na<sub>2</sub>O-8K<sub>2</sub>O-8MgO-22CaO-36B<sub>2</sub>O<sub>3</sub>-18SiO<sub>2</sub>-2P<sub>2</sub>O<sub>5</sub></td>
<td rowspan="3">67.7–86.7</td>
<td rowspan="3">0.8–9.7</td>
<td rowspan="3">[41, 42]</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 53 µm</td>
</tr>
<tr>
<td>Sintering condition: 600°C/1 h</td>
</tr>
<tr>
<td rowspan="3">GC-ICEL2</td>
<td>ICEL2 composition (%mol.): 45P<sub>2</sub>O<sub>5</sub>-26CaO-15Na<sub>2</sub>O-3SiO<sub>2</sub>-4K<sub>2</sub>O-7MgO</td>
<td rowspan="3">∼85</td>
<td rowspan="3">∼0.4</td>
<td rowspan="3">[36, 43]</td>
</tr>
<tr>
<td>Starting glass powders size &lt; 32 µm</td>
</tr>
<tr>
<td>Sintering condition: 610°C/3 h</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0885328211429193"><label>a</label><p>Glass names refer to acronym or denotation introduced in the corresponding reference(s).</p></fn>
<fn id="table-fn3-0885328211429193"><label>b</label><p>If present, the notation ‘GC-‘followed by the name of the glass means that the material is a glass-ceramic derived from the parent glass by means of a thermal treatment above the crystallization temperature.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>A comparison among typical stress–strain curves of the scaffolds produced in this work is reported in <xref ref-type="fig" rid="fig13-0885328211429193">Figure 13</xref>; especially for GC-BG5-1100 and GC-CEL2 scaffolds, a multipeak profile of the curves is clearly evident. The curves have a positive slope up to a first peak, after which the scaffold’s thinner struts begin to crack causing an apparent stress drop (negative slope); however, the scaffold was still able to bear higher loads and therefore the stress rises again. The repetition of this behavior gave a jagged stress–strain curve while the progressive cracking of scaffold’s trabeculae occurs; finally, when also the thicker struts are fractured, the curve has an ultimate negative slope. This behavior, typical for foam-like solids, was also observed by other authors, such as Jones et al.<sup><xref ref-type="bibr" rid="bibr44-0885328211429193">44</xref></sup> and Chen et al.,<sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref></sup> for glass-ceramic scaffolds.
<fig id="fig13-0885328211429193" position="float"><label>Figure 13.</label><caption><p>Comparison of typical stress-strain curves of GC-BG32-1180, GC-BG5-1100 and GC-CEL2 scaffolds.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig13.tif"/>
</fig></p>
<p>A few considerations about the relationship between scaffold strength and porosity are also presented as closing remarks. The scaffolds prepared in this work were all produced by the same fabrication method (sponge replication) and, therefore, their trabecular architecture can be considered quite similar. Hence, by adopting a remarkable simplification, it is possible to hypothesize that, for the same glass composition and particles size, the scaffold strength is only dependent on pore content (<italic>P</italic>) <italic>per se</italic>. Therefore, the scaffold compressive strength can be related to <italic>P</italic> by means of an empirical function (σ<sup>*</sup>) interpolating the measured values; the coefficient of determination <italic>R</italic><sup>2</sup> gives an evaluation about the ‘goodness of fitting’ of the model. Comparison among the fitting curves interpolating the data from GC-B5-1100, GC-BG32-1180, and GC-CEL2 scaffolds is reported in <xref ref-type="fig" rid="fig14-0885328211429193">Figure 14</xref>; we did not consider those Bioglass®-derived scaffold batches characterized by incomplete sintering of the struts (<xref ref-type="fig" rid="fig9-0885328211429193">Figures 9(a)</xref>–(<xref ref-type="fig" rid="fig9-0885328211429193">f</xref>)), which involves that scaffold strength is not dependent only by pore content <italic>per se</italic> but is also negatively affected by a high intrinsic brittleness of scaffold struts.
<fig id="fig14-0885328211429193" position="float"><label>Figure 14.</label><caption><p>Relationship between porosity and compressive strength of the glass-derived scaffolds produced in this work: (a) linear and (b) quadratic model data fitting.</p></caption><graphic xlink:href="10.1177_0885328211429193-fig14.tif"/>
</fig></p>
<p>The curve <inline-formula id="ilm2-0885328211429193"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="mml-math2-0885328211429193"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>GC</mml:mi><mml:mo>-</mml:mo><mml:mi>BG</mml:mi><mml:mn>5</mml:mn></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> could be interpreted as the results of a rigid, upward translation of the curve <inline-formula id="ilm3-0885328211429193"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="mml-math3-0885328211429193"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>GC</mml:mi><mml:mo>-</mml:mo><mml:mi>BG</mml:mi><mml:mn>32</mml:mn></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>; from the viewpoint of scaffold processing, this effect is regulated by the size of starting Bioglass® particles. The different slopes of the <inline-formula id="ilm4-0885328211429193"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="mml-math4-0885328211429193"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>GC</mml:mi><mml:mo>-</mml:mo><mml:mi>CEL</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> and <inline-formula id="ilm5-0885328211429193"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="mml-math5-0885328211429193"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>GC</mml:mi><mml:mo>-</mml:mo><mml:mi>BG</mml:mi><mml:mn>32</mml:mn></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> curves (the starting glass particles were sieved below 32 µm in both cases) can be attributable to different intrinsic properties of the materials (the ‘material effect’), such as the different micromechanical features of the crystalline phases of GC-CEL2 and GC-BG32. Increment of the strength of GC-CEL2 scaffolds is higher than that of GC-Bioglass® scaffolds when porosity decreases, that is, when the ‘material effect’ plays a more significant role.</p>
<p>As a general comment, a negative linear relationship between scaffold porosity and compressive strength can be found, with <italic>R</italic><sup>2</sup> above 0.80 (<xref ref-type="fig" rid="fig14-0885328211429193">Figure 14(a)</xref>). Gerhardt and Boccaccini<sup><xref ref-type="bibr" rid="bibr45-0885328211429193">45</xref></sup> showed that linear interpolation usually offers an acceptable approximation to describe the relationship between scaffold compressive strength and porosity, except for highly-porous Bioglass®-derived scaffolds<sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref></sup> due to the onset of instability phenomena related to their high brittleness. Hellmich and co-workers<sup><xref ref-type="bibr" rid="bibr46-0885328211429193">46</xref>,<xref ref-type="bibr" rid="bibr47-0885328211429193">47</xref></sup> developed micromechanical models of porous ceramics and found that nonlinear strength–porosity relations are in very good accordance with experimental results. Baino et al.<sup><xref ref-type="bibr" rid="bibr48-0885328211429193">48</xref></sup> suggested that a good fitting of experimental data can be obtained by using second-order polynomial functions; interpolation of experimental data by a quadratic model is reported in <xref ref-type="fig" rid="fig14-0885328211429193">Figure 14(b)</xref>. It is worth underlining that, as expected, <inline-formula id="ilm6-0885328211429193"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="mml-math6-0885328211429193"><mml:mrow><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mtext>quadr</mml:mtext></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mtext>lin</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> for all the considered scaffold batches.</p>
</sec>
<sec id="sec16-0885328211429193"><title>In vitro bioactivity</title>
<p><italic>in vitro</italic> bioactivity of sintered Bioglass® in form of both bulk samples and porous scaffolds was investigated in detail elsewhere.<sup><xref ref-type="bibr" rid="bibr8-0885328211429193">8</xref>,<xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref>,<xref ref-type="bibr" rid="bibr49-0885328211429193">49</xref></sup></p>
<p>As a representative example, the results of <italic>in vitro</italic> tests carried out on a GC-BG32-1180 scaffold after immersion for 7 days in SBF are shown in <xref ref-type="fig" rid="fig15-0885328211429193">Figure 15</xref>. Scaffold struts are homogeneously and continuously coated by a newly formed phase constituted by globe-shaped agglomerates (<xref ref-type="fig" rid="fig15-0885328211429193">Figure 15(a)</xref>), whose ‘cauliflower morphology’ is typical of apatite phase(s) grown on the surface of bioactive glasses. Compositional analysis (<xref ref-type="fig" rid="fig15-0885328211429193">Figure 15(b)</xref>) confirmed the calcium-phosphate nature of this layer, that revealed a molar ratio Ca/P = 1.65. Ca/P ratio is slightly lower than the theoretical one of natural HA (1.67) because the newly formed apatite phase is a mixture of amorphous and crystalline calcium phosphate, as suggested in other reports.<sup><xref ref-type="bibr" rid="bibr16-0885328211429193">16</xref></sup> The peak of silicon (Si) visible in <xref ref-type="fig" rid="fig15-0885328211429193">Figure 15(b)</xref> is attributable to the residual silica gel lying underneath the HA layer, according to the bioactivity mechanism proposed by Hench,<sup><xref ref-type="bibr" rid="bibr1-0885328211429193">1</xref>,<xref ref-type="bibr" rid="bibr4-0885328211429193">4</xref></sup> whereas the presence of silver (Ag) peaks is due to the metal coating necessary for EDS analysis.
<fig id="fig15-0885328211429193" position="float"><label>Figure 15.</label><caption><p><italic>In vitro</italic> bioactivity of the scaffolds after soaking for 7 days in SBF: (a) surface of GC-BG32-1180 (magnification 5000×) and (b) corresponding EDS pattern; polished cross-sections of resin-embedded (c) GC-BG32-1180 scaffold (magnification 200×) and (d) GC-CEL2 scaffold (magnification 240×).</p></caption><graphic xlink:href="10.1177_0885328211429193-fig15.tif"/>
</fig></p>
<p>After soaking in SBF, GC-BG32-1180 were also embedded in epoxy resin (Struers Epofix), cut and carefully polished by using SiC grit (from #600 to #4000) papers; one of the resulting cross sections is shown in <xref ref-type="fig" rid="fig15-0885328211429193">Figure 15(c)</xref>: the back-scattered mode adopted for this SEM analysis emphasizes the presence of the apatite layer grown on scaffold walls, as indicated in the picture (dark grey layer); the newly formed layer is compact, continuous and constitutes a thick ‘skin’ (up to ∼50 µm) on scaffold struts.</p>
<p>The high bioactive behavior of GC-BG32 scaffolds sintered at 1180°C for 3 h is an important finding that expands the observations performed by other authors. In 1992, Li et al.<sup><xref ref-type="bibr" rid="bibr50-0885328211429193">50</xref></sup> reported that crystallization of Bioglass® turns the bioactive glass into an inertlike material. More recently, this crucial issue was investigated in detail by Peitl et al.<sup><xref ref-type="bibr" rid="bibr51-0885328211429193">51</xref></sup> and Clupper et al.,<sup><xref ref-type="bibr" rid="bibr49-0885328211429193">49</xref></sup> who reported quantitative investigations about the relationship between crystallinity of Bioglass®-derived glass-ceramics and kinetics of apatite formation <italic>in vitro</italic>. The major crystalline phase Na<sub>2</sub>Ca<sub>2</sub>Si<sub>3</sub>O<sub>9</sub>, that nucleates during the process of sintering, decreases the kinetics of formation of HA on the Bioglass®-derived glass-ceramics, but does not totally suppress the growth of this bioactive layer. In this context, a further point should be underlined: surface reaction kinetics of a highly porous body (in this case a glass-ceramic scaffold) is faster than those of a dense product with analogous chemical/structural composition due to its higher surface area available for ion-exchange phenomena.</p>
<p>Comparing the SEM images reported in <xref ref-type="fig" rid="fig15-0885328211429193">Figures 15(c)</xref>,(d), the <italic>in vitro</italic> bioactivity of GC-CEL2 scaffold seems to be higher than that of GC-BG32-1180 sample, as evident from the difference of thickness of the HA layer formed on the struts of the two scaffolds. In this work, the maximum thickness of the HA layer (∼50 and ∼75 µm for GC-BG32-1180 and GC-CEL2 scaffolds, respectively), measured by using a proper tool of the SEM software, was assumed as a preliminary index to quantify and compare the <italic>in vitro</italic> bioactivity of the scaffolds. The kinetics of <italic>in vitro</italic> apatite formation on GC-CEL2 scaffold struts were recently investigated in more detail by Renghini et al.<sup><xref ref-type="bibr" rid="bibr52-0885328211429193">52</xref></sup></p>
<p>The presence of an apatite/HA layer on scaffold struts plays a key role for promoting the graft colonization by bone cells. It was demonstrated that osteoblasts attach preferably on HA agglomerates due to HA chemical and crystallographic similarity to bone mineral.<sup><xref ref-type="bibr" rid="bibr23-0885328211429193">23</xref></sup> Under this viewpoint, apatite layer can be viewed as a ‘biomimetic skin’ making the scaffold struts surface a highly biocompatible substrate apt for cells adhesion <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
</sec>
</sec>
</sec>
<sec id="sec17-0885328211429193" sec-type="conclusions"><title>Conclusions</title>
<p>In this work, Bioglass®- and CEL2-derived glass-ceramic scaffolds were fabricated through the sponge replication technique by an optimized schedule. Foam-like highly porous (∼70 %vol.) scaffolds with mechanical strength (∼2.5 MPa) actually comparable to that of cancellous bone were produced for the first time from commercial Bioglass® powders. In fact, by carefully designing the processing parameter and the sintering conditions, excellent densification of scaffold struts were achieved, which imparted high-strength properties to the final sintered scaffold. This is a significant finding in the context of biomaterials for bone tissue engineering and opens new perspectives towards a truly functional bone substitute suitable for clinical use. Comparing the features of Bioglass®- and CEL2-derived scaffolds, the latter exhibited a mechanical strength (4.5 ± 0.9 MPa) twice that of the former, although both had the same pore content (∼70 %vol.); this was due to the different sintering behavior of the two glasses and to the features of the different crystalline phases in the glass-ceramic scaffolds (‘material effect’). All scaffolds exhibited a trabecular architecture mimicking that of spongy bone, with a highly interconnected network of open macropores in the 100–600 µm range. Formation of a thick (up to ∼50 and ∼75 µm for Bioglass®- and CEL2-derived scaffolds, respectively) and continuous apatite layer on pore walls after <italic>in vitro</italic> tests (soaking for 7 days in SBF) demonstrated the excellent bioactivity of all produced scaffolds. Considering their bioactive, architectural, and mechanical features, the optimized Bioglass®- and CEL2-based scaffolds can be suggested as effective implants for bone substitution.</p>
</sec>
</body>
<back><ack>
<title>Acknowledgments</title>
<p>Regione Piemonte (Ricerca Sanitaria Finalizzata 2006 and 2008) are kindly acknowledged for supporting this research work.</p></ack>
<ref-list>
<title>References</title>
<ref id="bibr1-0885328211429193"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioceramics: from concept to clinic</article-title>. <source>J Am Ceram Soc</source> <year>1991</year>; <volume>74</volume>: <fpage>1487</fpage>–<lpage>1510</lpage>.</citation></ref>
<ref id="bibr2-0885328211429193"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioactive materials</article-title>. <source>Ceram Int</source> <year>1996</year>; <volume>22</volume>: <fpage>493</fpage>–<lpage>507</lpage>.</citation></ref>
<ref id="bibr3-0885328211429193"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Biomaterials: a forecast for the future</article-title>. <source>Biomaterials</source> <year>1998</year>; <volume>19</volume>: <fpage>1419</fpage>–<lpage>1423</lpage>.</citation></ref>
<ref id="bibr4-0885328211429193"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioceramics</article-title>. <source>J Am Ceram Soc</source> <year>1998</year>; <volume>81</volume>: <fpage>1705</fpage>–<lpage>1727</lpage>.</citation></ref>
<ref id="bibr5-0885328211429193"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorozhkin</surname><given-names>SV</given-names></name></person-group>. <article-title>Bioceramics of calcium orthophosphates</article-title>. <source>Biomaterials</source> <year>2010</year>; <volume>31</volume>: <fpage>1465</fpage>–<lpage>1485</lpage>.</citation></ref>
<ref id="bibr6-0885328211429193"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daculsi</surname><given-names>G</given-names></name><name><surname>Laboux</surname><given-names>O</given-names></name><name><surname>Malard</surname><given-names>O</given-names></name><name><surname>Weiss</surname><given-names>P</given-names></name></person-group>. <article-title>Current state of the art of biphasic calcium phosphate bioceramics</article-title>. <source>J Mater Sci Mater Med</source> <year>2003</year>; <volume>14</volume>: <fpage>195</fpage>–<lpage>200</lpage>.</citation></ref>
<ref id="bibr7-0885328211429193"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benaqqa</surname><given-names>C</given-names></name><name><surname>Chevalier</surname><given-names>J</given-names></name><name><surname>Saadaoui</surname><given-names>M</given-names></name><name><surname>Fantozzi</surname><given-names>G</given-names></name></person-group>. <article-title>Slow crack Growth behaviour of hydroxyapatite ceramics</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>6106</fpage>–<lpage>6112</lpage>.</citation></ref>
<ref id="bibr8-0885328211429193"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>The Story of Bioglass®</article-title>. <source>J Mater Sci Mater Med</source> <year>2006</year>; <volume>17</volume>: <fpage>967</fpage>–<lpage>978</lpage>.</citation></ref>
<ref id="bibr9-0885328211429193"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Gentleman</surname><given-names>E</given-names></name><name><surname>Polak</surname><given-names>J</given-names></name></person-group>. <article-title>Bioactive glass scaffolds for bone regeneration</article-title>. <source>Elements</source> <year>2007</year>; <volume>3</volume>: <fpage>393</fpage>–<lpage>399</lpage>.</citation></ref>
<ref id="bibr10-0885328211429193"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>J</given-names></name><name><surname>Gremillard</surname><given-names>L</given-names></name></person-group>. <article-title>Ceramics for medical applications: a picture for the next 20 years</article-title>. <source>J Eur Ceram Soc</source> <year>2009</year>; <volume>29</volume>: <fpage>1245</fpage>–<lpage>1255</lpage>.</citation></ref>
<ref id="bibr11-0885328211429193"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Splinter</surname><given-names>RJ</given-names></name><name><surname>Allen</surname><given-names>WC</given-names></name><name><surname>Greenlee</surname><given-names>TK</given-names></name></person-group>. <article-title>Bonding Mechanisms at the interface of ceramic prosthetic materials</article-title>. <source>J Biomed Mater Res</source> <year>1972</year>; <volume>2</volume>: <fpage>117</fpage>–<lpage>141</lpage>.</citation></ref>
<ref id="bibr12-0885328211429193"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baino F and Vitale-Brovarone</surname><given-names>C</given-names></name></person-group>. <article-title>Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future</article-title>. <source>J Biomed Mater Res A</source> <year>2011</year>; <volume>97</volume>: <fpage>514</fpage>–<lpage>535</lpage>.</citation></ref>
<ref id="bibr13-0885328211429193"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xynos</surname><given-names>ID</given-names></name><name><surname>Edgar</surname><given-names>AJ</given-names></name><name><surname>Buttery</surname><given-names>LD</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Polak</surname><given-names>JM</given-names></name></person-group>. <article-title>Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution</article-title>. <source>J Biomed Mater Res</source> <year>2001</year>; <volume>55</volume>: <fpage>151</fpage>–<lpage>157</lpage>.</citation></ref>
<ref id="bibr14-0885328211429193"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Genetic design of bioactive glasses</article-title>. <source>J Eur Ceram Soc</source> <year>2009</year>; <volume>29</volume>: <fpage>1257</fpage>–<lpage>1265</lpage>.</citation></ref>
<ref id="bibr15-0885328211429193"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>A</given-names></name><name><surname>Guldal</surname><given-names>NS</given-names></name><name><surname>Boccaccini</surname><given-names>AR</given-names></name></person-group>. <article-title>A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics</article-title>. <source>Biomaterials</source> <year>2011</year>; <volume>32</volume>: <fpage>2757</fpage>–<lpage>2774</lpage>.</citation></ref>
<ref id="bibr16-0885328211429193"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>QZ</given-names></name><name><surname>Thompson</surname><given-names>ID</given-names></name><name><surname>Boccaccini</surname><given-names>AR</given-names></name></person-group>. <article-title>45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering</article-title>. <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>2414</fpage>–<lpage>2425</lpage>.</citation></ref>
<ref id="bibr17-0885328211429193"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bretcanu</surname><given-names>O</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Misra</surname><given-names>SK</given-names></name><name><surname>Boccaccini</surname><given-names>AR</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name></person-group>. <article-title>Biodegradable polymer coated 45S5 bioglass-derived glass-ceramic scaffolds for bone tissue engineering</article-title>. <source>Glass Tech Eur J Glass Sci Tech A</source> <year>2007</year>; <volume>48</volume>: <fpage>227</fpage>–<lpage>234</lpage>.</citation></ref>
<ref id="bibr18-0885328211429193"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>SC</given-names></name><name><surname>Hsu</surname><given-names>HC</given-names></name><name><surname>Hsiao</surname><given-names>SH</given-names></name><name><surname>Ho</surname><given-names>WF</given-names></name></person-group>. <article-title>Preparation of porous 45S5 bioglass®-derived glass-ceramic scaffolds by using rice husk as a porogen additive</article-title>. <source>J Mater Sci Mater Med</source> <year>2009</year>; <volume>20</volume>: <fpage>1229</fpage>–<lpage>1236</lpage>.</citation></ref>
<ref id="bibr19-0885328211429193"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karageorgiou</surname><given-names>V</given-names></name><name><surname>Kaplan</surname><given-names>D</given-names></name></person-group>. <article-title>Porosity of 3D biomaterial scaffolds and osteogenesis</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>5474</fpage>–<lpage>5491</lpage>.</citation></ref>
<ref id="bibr20-0885328211429193"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellucci</surname><given-names>D</given-names></name><name><surname>Cannillo</surname><given-names>V</given-names></name><name><surname>Sola</surname><given-names>A</given-names></name></person-group>. <article-title>Shell scaffolds: a new approach towards high strength bioceramic scaffolds for bone regeneration</article-title>. <source>Mater Lett</source> <year>2010</year>; <volume>64</volume>: <fpage>203</fpage>–<lpage>206</lpage>.</citation></ref>
<ref id="bibr21-0885328211429193"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Baino</surname><given-names>F</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name></person-group>. <article-title>High strength bioactive glass-ceramic scaffolds for bone regeneration</article-title>. <source>J Mater Sci Mater Med</source> <year>2009</year>; <volume>20</volume>: <fpage>643</fpage>–<lpage>653</lpage>.</citation></ref>
<ref id="bibr22-0885328211429193"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name><name><surname>Robiglio</surname><given-names>L</given-names></name><name><surname>Martinasso</surname><given-names>G</given-names></name><name><surname>Canuto</surname><given-names>RA</given-names></name><name><surname>Muzio</surname><given-names>G</given-names></name></person-group>. <article-title>Biocompatible glass-ceramic materials for bone substitution</article-title>. <source>J Mater Sci Mater Med</source> <year>2008</year>; <volume>19</volume>: <fpage>471</fpage>–<lpage>478</lpage>.</citation></ref>
<ref id="bibr23-0885328211429193"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name><name><surname>Robiglio</surname><given-names>L</given-names></name><name><surname>Appendino</surname><given-names>P</given-names></name><name><surname>Bassi</surname><given-names>F</given-names></name><name><surname>Martinasso</surname><given-names>G</given-names></name><name><surname>Muzio</surname><given-names>G</given-names></name><name><surname>Canuto</surname><given-names>R</given-names></name></person-group>. <article-title>Development of glass-ceramic scaffolds for bone tissue engineering: characterisation, proliferation of human osteoblasts and nodule formation<italic/></article-title>. <source>Acta Biomater</source> <year>2007</year>; <volume>3</volume>: <fpage>199</fpage>–<lpage>208</lpage>.</citation></ref>
<ref id="bibr24-0885328211429193"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kokubo</surname><given-names>T</given-names></name><name><surname>Takadama</surname><given-names>H</given-names></name></person-group>. <article-title>How useful is SBF in predicting in vivo bone bioactivity?</article-title> <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>2907</fpage>–<lpage>2915</lpage>.</citation></ref>
<ref id="bibr25-0885328211429193"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erol</surname><given-names>M</given-names></name><name><surname>Kucukbayrak</surname><given-names>S</given-names></name><name><surname>Ersoy-Mericboyu</surname><given-names>A</given-names></name></person-group>. <article-title>Influence of particle size on the crystallization kinetics of glasses produced from waste materials</article-title>. <source>J Non-Cryst Solids</source> <year>2011</year>; <volume>357</volume>: <fpage>211</fpage>–<lpage>219</lpage>.</citation></ref>
<ref id="bibr26-0885328211429193"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bretcanu</surname><given-names>O</given-names></name><name><surname>Chatzistavrou</surname><given-names>X</given-names></name><name><surname>Paraskevpoulos</surname><given-names>K</given-names></name><name><surname>Conradt</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>I</given-names></name></person-group>. <article-title>and Boccaccini, A.R. Sintering and crystallization of 45S5 bioglass® powder</article-title>. <source>J Eur Ceram Soc</source> <year>2009</year>; <volume>29</volume>: <fpage>3299</fpage>–<lpage>3306</lpage>.</citation></ref>
<ref id="bibr27-0885328211429193"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Boccaccini</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>QZ</given-names></name></person-group>. <article-title>A two-scale model for simultaneous sintering and crystallization of glass–ceramic scaffolds for tissue engineering</article-title>. <source>Acta Biomater</source> <year>2008</year>; <volume>4</volume>: <fpage>1095</fpage>–<lpage>1103</lpage>.</citation></ref>
<ref id="bibr28-0885328211429193"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hruby</surname><given-names>A</given-names></name></person-group>. <article-title>Evaluation of glass-forming tendency by means of DTA</article-title>. <source>Czech J Phys</source> <year>1972</year>; <volume>22</volume>: <fpage>1187</fpage>–<lpage>1193</lpage>.</citation></ref>
<ref id="bibr29-0885328211429193"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>PC</given-names></name><name><surname>Raj</surname><given-names>R</given-names></name></person-group>. <article-title>Sintering and crystallization of glass at constant heating rate</article-title>. <source>J Am Ceram Soc</source> <year>1989</year>; <volume>69</volume>: <fpage>1564</fpage>–<lpage>1566</lpage>.</citation></ref>
<ref id="bibr30-0885328211429193"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferraris</surname><given-names>M</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name></person-group>. <article-title>Viscous phase sintering of particle-reinforced glass matrix composites</article-title>. <source>J Eur Ceram Soc</source> <year>1996</year>; <volume>16</volume>: <fpage>421</fpage>–<lpage>427</lpage>.</citation></ref>
<ref id="bibr31-0885328211429193"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>C</given-names></name><name><surname>Pascual</surname><given-names>MJ</given-names></name><name><surname>Duran</surname><given-names>A</given-names></name></person-group>. <article-title>Glass-forming ability, sinterability and thermal properties in the system RO-BaO-SiO<sub>2</sub> (<italic>R</italic> = Mg, Zn)</article-title>. <source>J Non-Cryst Solids</source> <year>2004</year>; <volume>348</volume>: <fpage>149</fpage>–<lpage>155</lpage>.</citation></ref>
<ref id="bibr32-0885328211429193"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Huang</surname><given-names>LC</given-names></name><name><surname>Shen</surname><given-names>P</given-names></name></person-group>. <article-title>Na<sub>2</sub>CaSi<sub>2</sub>O<sub>6</sub>-P<sub>2</sub>O<sub>5</sub> Based bioactive glasses. Part I: elasticity and structure</article-title>. <source>J Non-Cryst Solids</source> <year>2005</year>; <volume>351</volume>: <fpage>3195</fpage>–<lpage>3203</lpage>.</citation></ref>
<ref id="bibr33-0885328211429193"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lefebvre</surname><given-names>L</given-names></name><name><surname>Chevalier</surname><given-names>J</given-names></name><name><surname>Gremillard</surname><given-names>L</given-names></name><name><surname>Zenati</surname><given-names>R</given-names></name><name><surname>Thollet</surname><given-names>G</given-names></name><name><surname>Bernache-Assolant</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Structural transformation of bioactive glass 45S5 with thermal treatments</article-title>. <source>Acta Mater</source> <year>2007</year>; <volume>55</volume>: <fpage>3305</fpage>–<lpage>3313</lpage>.</citation></ref>
<ref id="bibr34-0885328211429193"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lefebvre</surname><given-names>L</given-names></name><name><surname>Gremillard</surname><given-names>L</given-names></name><name><surname>Chevalier</surname><given-names>J</given-names></name><name><surname>Zenati</surname><given-names>R</given-names></name><name><surname>Bernache-Assolant</surname><given-names>D</given-names></name></person-group>. <article-title>Sintering Behaviour of 45S5 bioactive glass</article-title>. <source>Acta Biomater</source> <year>2008</year>; <volume>4</volume>: <fpage>1894</fpage>–<lpage>1903</lpage>.</citation></ref>
<ref id="bibr35-0885328211429193"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellucci</surname><given-names>D</given-names></name><name><surname>Cannillo</surname><given-names>V</given-names></name><name><surname>Sola</surname><given-names>A</given-names></name><name><surname>Chiellini</surname><given-names>F</given-names></name><name><surname>Gazzarri</surname><given-names>M</given-names></name><name><surname>Migone</surname><given-names>C</given-names></name></person-group>. <article-title>Macroporous Bioglass®-derived scaffolds for bone tissue regeneration</article-title>. <source>Ceram Int</source> <year>2011</year>; <volume>37</volume>: <fpage>1575</fpage>–<lpage>1585</lpage>.</citation></ref>
<ref id="bibr36-0885328211429193"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Baino</surname><given-names>F</given-names></name><name><surname>Bretcanu</surname><given-names>O</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name></person-group>. <article-title>Foam-like scaffolds for bone tissue engineering based on a novel couple of silicate-phosphate specular glasses: synthesis and properties</article-title>. <source>J Mater Sci Mater Med</source> <year>2009</year>; <volume>20</volume>: <fpage>2197</fpage>–<lpage>2205</lpage>.</citation></ref>
<ref id="bibr37-0885328211429193"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Baino</surname><given-names>F</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name></person-group>. <article-title>Feasibility and tailoring of bioactive glass-ceramic scaffolds with gradient of porosity for bone grafting</article-title>. <source>J Biomater Appl</source> <year>2010</year>; <volume>24</volume>: <fpage>693</fpage>–<lpage>712</lpage>.</citation></ref>
<ref id="bibr38-0885328211429193"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Miola</surname><given-names>M</given-names></name><name><surname>Balagna</surname><given-names>C</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name></person-group>. <article-title>3D Glass-ceramic scaffolds with antibacterial properties for bone grafting</article-title>. <source>Chem Eng J</source> <year>2008</year>; <volume>137</volume>: <fpage>129</fpage>–<lpage>136</lpage>.</citation></ref>
<ref id="bibr39-0885328211429193"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balagna</surname><given-names>C</given-names></name><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Miola</surname><given-names>M</given-names></name><name><surname>Canuto</surname><given-names>RA</given-names></name><name><surname>Saracino</surname><given-names>S</given-names></name><name><surname>Muzio</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Biocompatibility and antibacterial effect of silver doped 3D-glass-ceramic scaffolds for bone grafting</article-title>. <source>J Biomater Appl</source> <year>2011</year>; <volume>25</volume>: <fpage>595</fpage>–<lpage>617</lpage>.</citation></ref>
<ref id="bibr40-0885328211429193"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Q</given-names></name><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Sonny Bal</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>RF</given-names></name><name><surname>Day</surname><given-names>DE</given-names></name></person-group>. <article-title>Mechanical and <italic>in vitro</italic> performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique</article-title>. <source>Acta Biomater</source> <year>2008</year>; <volume>4</volume>: <fpage>1854</fpage>–<lpage>1864</lpage>.</citation></ref>
<ref id="bibr41-0885328211429193"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Rahaman</surname><given-names>MN</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name></person-group>. <article-title>and Liu, X. In vitro evaluation of borate-based bioactive glass scaffolds prepared by a polymer foam replication method</article-title>. <source>Mater Sci Eng C</source> <year>2009</year>; <volume>29</volume>: <fpage>2275</fpage>–<lpage>2281</lpage>.</citation></ref>
<ref id="bibr42-0885328211429193"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>WW</given-names></name></person-group>. <article-title>Bioactive borosilicate glass scaffolds: improvement on the strength of glass-based scaffolds for tissue engineering</article-title>. <source>J Mater Sci Mater Med</source> <year>2009</year>; <volume>20</volume>: <fpage>365</fpage>–<lpage>372</lpage>.</citation></ref>
<ref id="bibr43-0885328211429193"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Ciapetti</surname><given-names>G</given-names></name><name><surname>Leonardi</surname><given-names>E</given-names></name><name><surname>Baldini</surname><given-names>N</given-names></name><name><surname>Bretcanu</surname><given-names>O</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Resorbable glass-ceramic phosphate-based scaffolds for bone tissue engineering: synthesis, properties and in vitro effects on human marrow stromal cells</article-title>. <source>J Biomater Appl</source> <year>2011</year>; <volume>26</volume>: <fpage>465</fpage>–<lpage>489</lpage>.</citation></ref>
<ref id="bibr44-0885328211429193"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Ehrenfried</surname><given-names>LM</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Optimising bioactive glass scaffolds for bone tissue engineering</article-title>. <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>964</fpage>–<lpage>973</lpage>.</citation></ref>
<ref id="bibr45-0885328211429193"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname><given-names>LC</given-names></name><name><surname>Boccaccini</surname><given-names>AR</given-names></name></person-group>. <article-title>Bioactive glass and glass-ceramic scaffolds for bone tissue engineering</article-title>. <source>Materials</source> <year>2010</year>; <volume>3</volume>: <fpage>3867</fpage>–<lpage>3910</lpage>.</citation></ref>
<ref id="bibr46-0885328211429193"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fritsch</surname><given-names>A</given-names></name><name><surname>Dormieux</surname><given-names>L</given-names></name><name><surname>Hellmich</surname><given-names>C</given-names></name><name><surname>Sanahuja</surname><given-names>J</given-names></name></person-group>. <article-title>Mechanical behavior of hydroxyapatite biomaterials: an experimentally validated micromechanical model for elasticity and strength</article-title>. <source>J Biomed Mater Res A</source> <year>2007</year>; <volume>88</volume>: <fpage>149</fpage>–<lpage>161</lpage>.</citation></ref>
<ref id="bibr47-0885328211429193"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malasoma</surname><given-names>A</given-names></name><name><surname>Fritsch</surname><given-names>A</given-names></name><name><surname>Kohlhauser</surname><given-names>C</given-names></name><name><surname>Brynk</surname><given-names>T</given-names></name><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name><name><surname>Pakiela</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Micromechanics of bioresorbable porous CEL2 glass ceramic scaffolds for bone tissue engineering</article-title>. <source>Adv Appl Ceram</source> <year>2008</year>; <volume>107</volume>: <fpage>277</fpage>–<lpage>286</lpage>.</citation></ref>
<ref id="bibr48-0885328211429193"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baino</surname><given-names>F</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name><name><surname>Vitale-Brovarone</surname><given-names>C</given-names></name></person-group>. <article-title>3-D high strength glass-ceramic scaffolds containing fluoroapatite for load-bearing bone portions replacement</article-title>. <source>Mater Sci Eng C</source> <year>2009</year>; <volume>29</volume>: <fpage>2055</fpage>–<lpage>2062</lpage>.</citation></ref>
<ref id="bibr49-0885328211429193"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clupper</surname><given-names>DC</given-names></name><name><surname>Mecholsky</surname><given-names>JJ</given-names><suffix>Jr.</suffix></name><name><surname>LaTorre</surname><given-names>GP</given-names></name></person-group>. <article-title>and Greenspan, D.C. Bioactivity of tape cast and sintered glass-ceramic in simulated body fluid</article-title>. <source>Biomaterials</source> <year>2002</year>; <volume>23</volume>: <fpage>2599</fpage>–<lpage>2606</lpage>.</citation></ref>
<ref id="bibr50-0885328211429193"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Kokubo</surname><given-names>T</given-names></name></person-group>. <article-title>The effect of residual glassy phase in a bioactive glass-ceramic on the formation of its surface apatite layer <italic>in vitro</italic></article-title>. <source>J Mater Sci Mater Med</source> <year>1992</year>; <volume>3</volume>: <fpage>452</fpage>–<lpage>456</lpage>.</citation></ref>
<ref id="bibr51-0885328211429193"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peitl</surname><given-names>FO</given-names></name><name><surname>LaTorre</surname><given-names>GP</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Effect of crystallization on apatite-layer formation of bioactive glass 45S5</article-title>. <source>J Biomed Mater Res</source> <year>1996</year>; <volume>30</volume>: <fpage>509</fpage>–<lpage>514</lpage>.</citation></ref>
<ref id="bibr52-0885328211429193"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renghini</surname><given-names>C</given-names></name><name><surname>Komlev</surname><given-names>V</given-names></name><name><surname>Fiori</surname><given-names>F</given-names></name><name><surname>Verné</surname><given-names>E</given-names></name><name><surname>Baino</surname><given-names>F</given-names></name></person-group>. <article-title>and Vitale-Brovarone, C. Micro-CT studies on 3-D bioactive glass-ceramic scaffolds for bone regeneration</article-title>. <source>Acta Biomater</source> <year>2009</year>; <volume>5</volume>: <fpage>1328</fpage>–<lpage>1337</lpage>.</citation></ref>
</ref-list>
</back>
</article>